Ben Jones

4.4k total citations
101 papers, 2.6k citations indexed

About

Ben Jones is a scholar working on Surgery, Endocrinology, Diabetes and Metabolism and Molecular Biology. According to data from OpenAlex, Ben Jones has authored 101 papers receiving a total of 2.6k indexed citations (citations by other indexed papers that have themselves been cited), including 52 papers in Surgery, 49 papers in Endocrinology, Diabetes and Metabolism and 48 papers in Molecular Biology. Recurrent topics in Ben Jones's work include Diabetes Treatment and Management (42 papers), Pancreatic function and diabetes (39 papers) and Receptor Mechanisms and Signaling (37 papers). Ben Jones is often cited by papers focused on Diabetes Treatment and Management (42 papers), Pancreatic function and diabetes (39 papers) and Receptor Mechanisms and Signaling (37 papers). Ben Jones collaborates with scholars based in United Kingdom, United States and Germany. Ben Jones's co-authors include Steven McTaggart, Stephen R. Bloom, Alejandra Tomás, Tricia Tan, Guy A. Rutter, Kerry Atkinson, Gary Brooke, Johannes Broichhagen, David J. Hodson and James Minnion and has published in prestigious journals such as Journal of Biological Chemistry, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Ben Jones

96 papers receiving 2.5k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ben Jones United Kingdom 29 1.2k 940 926 547 385 101 2.6k
Patrick Harriott United Kingdom 34 958 0.8× 1.4k 1.5× 773 0.8× 825 1.5× 172 0.4× 73 2.8k
Luigi Sironi Italy 39 1.4k 1.2× 334 0.4× 619 0.7× 470 0.9× 125 0.3× 100 4.4k
Timothy L. Reudelhuber Canada 38 1.7k 1.4× 1.1k 1.2× 376 0.4× 245 0.4× 152 0.4× 81 3.8k
Serge P. Bottari France 32 2.1k 1.8× 1.6k 1.7× 449 0.5× 582 1.1× 224 0.6× 73 4.3k
Carla Perego Italy 30 1.2k 1.0× 600 0.6× 865 0.9× 552 1.0× 89 0.2× 73 2.9k
David A. Katz United States 27 1.1k 0.9× 1.1k 1.1× 487 0.5× 259 0.5× 203 0.5× 64 3.4k
Christoph Korbmacher Germany 41 3.5k 3.0× 494 0.5× 338 0.4× 688 1.3× 178 0.5× 129 4.8k
Mihaela Mocanu United Kingdom 36 2.0k 1.7× 873 0.9× 733 0.8× 410 0.7× 46 0.1× 82 5.4k
Lan Mao United States 39 2.5k 2.2× 607 0.6× 409 0.4× 389 0.7× 189 0.5× 84 5.1k
Masanobu Yamada Japan 31 1.1k 1.0× 1.7k 1.8× 803 0.9× 316 0.6× 177 0.5× 208 3.7k

Countries citing papers authored by Ben Jones

Since Specialization
Citations

This map shows the geographic impact of Ben Jones's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ben Jones with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ben Jones more than expected).

Fields of papers citing papers by Ben Jones

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ben Jones. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ben Jones. The network helps show where Ben Jones may publish in the future.

Co-authorship network of co-authors of Ben Jones

This figure shows the co-authorship network connecting the top 25 collaborators of Ben Jones. A scholar is included among the top collaborators of Ben Jones based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ben Jones. Ben Jones is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Levitz, Joshua, et al.. (2024). Red and far-red cleavable fluorescent dyes for self-labelling enzyme protein tagging and interrogation of GPCR co-internalization. RSC Chemical Biology. 6(1). 11–20. 1 indexed citations
3.
Shchepinova, Maria M., Guy A. Rutter, Asuka Inoue, et al.. (2024). Engineered mini-G proteins block the internalization of cognate GPCRs and disrupt downstream intracellular signaling. Science Signaling. 17(843). eabq7038–eabq7038. 9 indexed citations
4.
Sangwung, Panjamaporn, et al.. (2024). Class B1 GPCRs: insights into multireceptor pharmacology for the treatment of metabolic disease. American Journal of Physiology-Endocrinology and Metabolism. 327(5). E600–E615. 1 indexed citations
5.
Bitsi, Stavroula, et al.. (2023). Divergent acute versus prolonged pharmacological GLP-1R responses in adult β cell–specific β-arrestin 2 knockout mice. Science Advances. 9(18). eadf7737–eadf7737. 20 indexed citations
6.
Eichhorst, Jenny, Thorben Cordes, Benjamin Dietzek‐Ivanšić, et al.. (2022). N-Methyl deuterated rhodamines for protein labelling in sensitive fluorescence microscopy. Chemical Science. 13(29). 8605–8617. 28 indexed citations
7.
Ast, Julia, Dorien A. Roosen, Joon Lee, et al.. (2022). Sulfonated red and far-red rhodamines to visualize SNAP- and Halo-tagged cell surface proteins. Organic & Biomolecular Chemistry. 20(30). 5967–5980. 23 indexed citations
8.
Reynolds, Christopher A., et al.. (2022). Biased agonism and polymorphic variation at the GLP-1 receptor: Implications for the development of personalised therapeutics. Pharmacological Research. 184. 106411–106411. 28 indexed citations
9.
Jones, Ben. (2021). The therapeutic potential of GLP‐1 receptor biased agonism. British Journal of Pharmacology. 179(4). 492–510. 59 indexed citations
10.
Pickford, Philip, Zijian Fang, Stavroula Bitsi, et al.. (2020). Signalling, trafficking and glucoregulatory properties of glucagon‐like peptide‐1 receptor agonists exendin‐4 and lixisenatide. British Journal of Pharmacology. 177(17). 3905–3923. 34 indexed citations
11.
Anand, Uma, et al.. (2020). CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons. SHILAP Revista de lepidopterología. 1 indexed citations
12.
Bitsi, Stavroula, et al.. (2020). Spatiotemporal control of GLP-1 receptor activity. Current Opinion in Endocrine and Metabolic Research. 16. 19–27. 17 indexed citations
13.
Gutzeit, Vanessa A., Julia Ast, Joon Lee, et al.. (2020). Interrogating surface versus intracellular transmembrane receptor populations using cell-impermeable SNAP-tag substrates. Chemical Science. 11(30). 7871–7883. 30 indexed citations
14.
Anand, Uma, Ben Jones, Yuri E. Korchev, et al.. (2020). <p>CBD Effects on TRPV1 Signaling Pathways in Cultured DRG Neurons</p>. Journal of Pain Research. Volume 13. 2269–2278. 52 indexed citations
15.
Frémaux, Juliette, Robert Zimmer, Didier Rognan, et al.. (2019). Ureidopeptide GLP-1 analogues with prolonged activity in vivo via signal bias and altered receptor trafficking. Chemical Science. 10(42). 9872–9879. 27 indexed citations
16.
Buenaventura, Teresa, Stavroula Bitsi, Thomas Burgoyne, et al.. (2019). Agonist-induced membrane nanodomain clustering drives GLP-1 receptor responses in pancreatic beta cells. PLoS Biology. 17(8). e3000097–e3000097. 66 indexed citations
17.
Koch, Marion, Jaimini Cegla, Ben Jones, et al.. (2019). The effects of dyslipidaemia and cholesterol modulation on erythrocyte susceptibility to malaria parasite infection. Malaria Journal. 18(1). 381–381. 11 indexed citations
18.
Singh, A. Jonathan, Vimal Patel, Ben Jones, et al.. (2018). Zampanolides B–E from the Marine Sponge Cacospongia mycofijiensis: Potent Cytotoxic Macrolides with Microtubule-Stabilizing Activity. Journal of Natural Products. 81(11). 2539–2544. 20 indexed citations
19.
D'Angio, G J, N. E. Breslow, Edward S. Baum, et al.. (2015). Management of Children with Wilms� Tumor: Defining the Risk-Benefit Ratio1. Frontiers of radiation therapy and oncology. 16. 30–39.
20.
Jones, Ben, et al.. (2012). Keeping Kidneys: Most Countries Struggle to Meet the Demand for Transplant Kidneys, but a Few Are Reaping the Benefits of Systems Dedicated to Increasing the Number of Organ Donations after Death. Bulletin of the World Health Organization. 90(10). 718. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Patrick Harriott Breakdown of academic impact, for papers by Luigi Sironi Breakdown of academic impact, for papers by Timothy L. Reudelhuber Breakdown of academic impact, for papers by Serge P. Bottari Breakdown of academic impact, for papers by Carla Perego Breakdown of academic impact, for papers by David A. Katz Breakdown of academic impact, for papers by Christoph Korbmacher Breakdown of academic impact, for papers by Mihaela Mocanu Breakdown of academic impact, for papers by Lan Mao Breakdown of academic impact, for papers by Masanobu Yamada
Rankless by CCL
2026